Company on track to deliver five Investigational New Drug (IND) applications as part of ‘5 by 5’ solid tumor strategy...
PALO ALTO, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative...
Webcast on December 17 at 8:00 AM EST to feature ALX Oncology leadership and study principal investigator Alberto J. Montero,...
CTO Role to Focus on Growth from New Market and Revenue StrategiesLAKE FOREST, Ill., Dec. 12, 2024 (GLOBE NEWSWIRE) --...
Evaxion’s AI-Immunology™ platform allows for the design of precision cancer vaccines targeting non-conventional ERV tumor antigens shared across patientsNovel preclinical...
Driving early drug discovery from gene to leadStrengthening collaborations and accessibility across North America Milan, Italy & Cambridge, MA, USA...
Dublin, Ireland--(Newsfile Corp. - December 12, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) is pleased to announce...
NEW YORK, Dec. 11, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global medical gas blenders...
LONDON, UK / ACCESSWIRE / December 11, 2024 / Nanomerics Ltd., a private speciality pharmaceutical company today announced that dosing...
'Doceree 360 (2024 Edition)' attempts to equip pharma marketers with top and latest trends and industry best practices to craft...
LEWES, Del., Dec. 11, 2024 /PRNewswire/ --The CRO Services Market is expanding rapidly as pharmaceutical and biotechnology companies increasingly outsource...
Rapidly growing pharmaceutical services platform leadership recognized for making significant contributions to healthcare marketing and communications. NASHVILLE, Tenn., Dec. 11, 2024...
New Initiative Sets Standards in Data Vendor Compliance, Strengthening Client Confidence in Third-Party Data Sources NEW YORK, Dec. 11, 2024...
PHILADELPHIA, Dec. 11, 2024 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, announced today the...
BASEL, Switzerland and BOSTON, Dec. 11, 2024 /PRNewswire/ -- Lyfegen, a global leader in drug rebate management technology, today announced...
STATEN ISLAND, NY / ACCESSWIRE / December 11, 2024 / Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company") (NASDAQ:ACXP), a late-stage...
Dry Powder Epinephrine Product Demonstrates Reliable and Consistent Delivery in Real-World Dosing Situations with a Heat-Stable Formulation RALEIGH, NC /...
LOS ANGELES, Dec. 11, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company, announced today that the Center for...
KNOXVILLE, Tenn., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) announced today the...
The trial (NCT06207370) evaluates tafenoquine combined with standard treatment for babesiosis, addressing a critical unmet medical need.The clinical site is...